MENU

BOLD Stock Tickeron detected bullish Stock Pattern: Three Rising Valleys on September 17, 2025

A.I.dvisor
at Tickeron.com
Loading...
Three Rising Valleys
BOLD - Boundless Bio
Tickeron
Emerged: 09/17/25
Breakout: $1.17
Price: $1.15
Target price: $1.23
A.I.dvisor detected a bullish Three Rising Valleys pattern for BOLD stock. This pattern was detected on September 17, 2025 . The odds of reaching the target price are . The Three Rising Valleys pattern forms when three minor Lows (1, 3, 5) are arranged along an upward sloping trend line. Consider buying a security or call option at the breakout price level. When trading, wait for the confirmation move, which is when the price rises above the breakout level.

BOLD in +3.57% Uptrend, advancing for three consecutive days on September 03, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BOLD advanced for three days, in of 62 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 18, 2025. You may want to consider a long position or call options on BOLD as a result. In of 21 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BOLD just turned positive on September 03, 2025. Looking at past instances where BOLD's MACD turned positive, the stock continued to rise in of 13 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 14 cases where BOLD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 11 cases where BOLD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

BOLD moved below its 50-day moving average on September 12, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BOLD crossed bearishly below the 50-day moving average on September 02, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 3 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.208) is normal, around the industry mean (19.798). P/E Ratio (0.156) is within average values for comparable stocks, (53.784). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.169). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (333.591).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BOLD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BOLD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BOLD showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of gene therapy products for patients with serious rare diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9880 Campus Point Drive
Phone
+1 858 766-9912
Employees
72
Web
https://www.boundlessbio.com